Nsclc Clinical Trials

ReadTheTrial indexes 3 studies for Nsclc. The most common development stage is N/A (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

3 clinical trials found for Nsclc.

Pipeline by Phase

PhaseTrialsDistribution
N/A 2
67%
Phase 2 1
33%

Trial Status Breakdown

Trials for Nsclc

Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered Advanced/Metastatic Non-small Cell Lung Cancer: a Prospective, Observational Study

NCT07516015 · NOT YET RECRUITING · N/A

Randomized Phase II Trial of Neoadjuvant and Adjuvant Atezolizumab With or Without Tiragolumab in Conjunction With Chemoradiotherapy for Unresectable Stage III NSCLC

NCT05798663 · ACTIVE NOT RECRUITING · Phase 2

Hypofractionated Radiotherapy vs Single Fraction Radiosurgery for Brain Metastasis Patients on Immunotherapy (HYPOGRYPHE)

NCT05703269 · ACTIVE NOT RECRUITING · N/A

Frequently Asked Questions

What clinical trials are available for Nsclc?

There are 3 clinical trials listed for Nsclc. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Nsclc trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Nsclc trials in?

Current Nsclc trials are distributed across: N/A (2), Phase 2 (1).

Find More Trials